Purification Methodology for Viable and Infective Plasmodium vivax Gametocytes That Is Compatible with Transmission-Blocking Assays

被引：9
|
作者：
Vera, Omaira [1 ,2 ]
de Brito, Paula Brelas [2 ]
Albrecht, Letusa [1 ,3 ]
Monick Martins-Campos, Keillen [2 ,4 ]
Pimenta, Paulo F. P. [5 ]
Monteiro, Wuelton M. [2 ,4 ]
Lacerda, Marcus V. G. [2 ,6 ]
Lopes, Stefanie C. P. [1 ,2 ,6 ]
Costa, Fabio T. M. [1 ]
机构：
[1] Univ Estadual Campinas, UNICAMP, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil
[2] Fundacao Med Trop Dr Heitor Vieira Dourado, Gerencia Malaria, Manaus, Amazonas, Brazil
[3] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, Parana, Brazil
[4] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil
[5] Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil
[6] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 10期
基金：
巴西圣保罗研究基金会;
关键词：
MALARIA; BLOOD;
D O I：
10.1128/AAC.01136-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Significant progress toward the control of malaria has been achieved, especially regarding Plasmodium falciparum infections. However, the unique biology of Plasmodium vivax hampers current control strategies. The early appearance of P. vivax gametocytes in the peripheral blood and the impossibility of culturing this parasite are major drawbacks. Using blood samples from 40 P. vivax-infected patients, we describe here a methodology to purify viable gametocytes and further infect anophelines. This method opens new avenues to validate transmission-blocking strategies.
引用
收藏
页码：6638 / 6641
页数：4
相关论文
共 50 条
  • [41] Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China
    Hui Feng
    Bhavna Gupta
    Meilian Wang
    Wenqi Zheng
    Li Zheng
    Xiaotong Zhu
    Yimei Yang
    Qiang Fang
    Enjie Luo
    Qi Fan
    Takafumi Tsuboi
    Yaming Cao
    Liwang Cui
    Parasites & Vectors, 8
  • [42] Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development
    Asali, Soheila
    Raz, Abbasali
    Turki, Habibollah
    Mafakher, Ladan
    Razmjou, Elham
    Solaymani-Mohammadi, Shahram
    INFECTION GENETICS AND EVOLUTION, 2021, 89
  • [43] Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes
    Lucantoni, Leonardo
    Fidock, David A.
    Avery, Vicky M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2097 - 2107
  • [44] A Novel Ex Vivo Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes
    Ouologuem, Dinkorma T.
    Dembele, Laurent
    Dara, Antoine
    Kone, Aminatou K.
    Diallo, Nouhoum
    Sangare, Cheick P. O.
    Ballo, Fatoumata, I
    Dao, Francois
    Goita, Siaka
    Haidara, Aboubecrin S.
    Traore, Aliou
    Niangaly, Amadou B.
    Dama, Souleymane
    Sissoko, Sekou
    Sogore, Fanta
    Dara, Jacob N.
    Barre, Yacouba N.
    Daou, Amadou
    Cisse, Fatoumata
    Diakite, Ousmaila
    Doumbia, Diagassan
    Koumare, Sekou
    Fofana, Bakary
    Tandina, Fatalmoudou
    Sylla, Daman
    Sacko, Adama
    Coulibaly, Mamadou
    Tekete, Mamadou M.
    Ouattara, Amed
    Djimde, Abdoulaye A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [45] PLASMODIUM-FALCIPARUM - NATURAL AND EXPERIMENTAL TRANSMISSION-BLOCKING IMMUNITY
    TARGETT, GAT
    IMMUNOLOGY LETTERS, 1988, 19 (03) : 235 - 240
  • [46] Plasmodium Dipeptidyl Aminopeptidases as Malaria Transmission-Blocking Drug Targets
    Tanaka, Takeshi Q.
    Deu, Edgar
    Molina-Cruz, Alvaro
    Ashburne, Michael J.
    Ali, Omar
    Suri, Amreena
    Kortagere, Sandhya
    Bogyo, Matthew
    Williamsona, Kim C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (10) : 4645 - 4652
  • [47] A step forward for Plasmodium falciparum malaria transmission-blocking vaccines
    Beeson, James G.
    Chan, Jo-Anne
    LANCET INFECTIOUS DISEASES, 2023, 23 (11): : 1210 - 1212
  • [48] Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination
    Thomas C. S. Martin
    Joseph M. Vinetz
    Malaria Journal, 17
  • [49] Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination
    Martin, Thomas C. S.
    Vinetz, Joseph M.
    MALARIA JOURNAL, 2018, 17
  • [50] Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine
    Miyata, Takeshi
    Harakuni, Tetsuya
    Sugawa, Hideki
    Sattabongkot, Jetsumon
    Kato, Aki
    Tachibana, Mayumi
    Torii, Motomi
    Tsuboi, Takafumi
    Arakawa, Takeshi
    VACCINE, 2011, 29 (15) : 2720 - 2726
12345